Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist
Didier Pruneau, Jean Luc Paquet, Jean Michel Luccarini et al. · Immunopharmacology · 1999
Cited by 95 works. doi:10.1016/s0162-3109(99)00128-9
Authors
- Didier Pruneau
- Jean Luc Paquet
- Jean Michel Luccarini
- Evelyne Defrêne
- Chantal Fouchet
- Rose‐Marie Franck
- Bruno Loillier
- Pierre Bélichard
- Hervé Duclos
- Béatrice Cremers
- Pierre Dodey
References
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
- Pharmacology of bradykinin and related kinins.
- Bioregulation of kinins: kallikreins, kininogens, and kininases.
- Bradykinin and inflammatory pain
- Bicistronic Vector for the Creation of Stable Mammalian Cell Lines that Predisposes All Antibiotic-Resistant Cells to Express Recombinant Protein
- Bradykinin receptors: Pharmacological properties and biological roles
- Kinins and kinin receptors in the nervous system
- Effects of Bradykinin on Permeability and Diameter of Pial Vessels In vivo
- Mechanisms of Bradykinin-Induced Cerebral Vasodilatation in Rats
- Kinins act on B1 or B2 receptors to release conjointly endothelium‐derived relaxing factor and prostacyclin from bovine aortic endothelial cells